SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: g.w. barnard who wrote (10384)7/2/1998 1:58:00 PM
From: VLAD  Read Replies (2) of 23519
 
gw,

I guess that we know that international sales will do well. We also know that we will see a loss (First call consensus -.29) in Q2. Question is what do the institutions want to hear regarding domestic sales/marketing. I don't think the rental sales force was a bad idea--I don't think even a relationship with a big player would have mattered on the effect of the Viagra craze. I think the institutions would rather hear that a big brand name player is involved but I don't know that it will really effect the domestic script numbers. The Viagra craze is starting to settle and now with the safety issues alone we may see a natural rebound of script numbers. As I said before if the new scripts go up over 4,000 by months end, everything will end up fine. I think we will achieve those numbers without much problem.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News